Correction to: Nature Communications https://doi.org/10.1038/s41467-020-20162-8, published online 4 January 2021.
This Article contained errors in the “Methods” section. In the first line of the “Methods” section, the samples were incorrectly described as “Between January 2017 to July 2019, a total of 12,337 patients with >40 different cancer types were enrolled at Geneplus Medical Laboratory (Beijing, China)”. The correct version reads “Between January 2017 to June 2019, a total of 12,337 patients with >40 different cancer types were enrolled at Geneplus Medical Laboratory (Beijing, China)”.
Additionally, in the “Methods” section entitled “Targeted deep sequencing for circulating cfDNA and WBC DNA” in the second paragraph, second sentence, it was incorrectly stated that “Afterward, all libraries were hybridized to self-built probes, and DNA sequencing was performed using the MGISeq-2000 Sequencing System (BGI, Shenzhen, China) per the manufacturer’s guidelines”. The correct sentence states “Afterward, all libraries were hybridized to self-built probes, and DNA sequencing was performed using the Gene+Seq-2000 sequencing system (GenePlus-Suzhou, Suzhou, China) per the manufacturer’s guidelines”. These errors have been corrected in the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, Y., Yao, Y., Xu, Y. et al. Author Correction: Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat Commun 12, 1048 (2021). https://doi.org/10.1038/s41467-021-21285-2
Published:
DOI: https://doi.org/10.1038/s41467-021-21285-2
This article is cited by
-
Circulating nucleic acids as liquid biopsies for disease prediction, screening and diagnosis
Science China Chemistry (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
